CYP 2.33% 21.0¢ cynata therapeutics limited

News: CYP Cynata Therapeutics seeks trading halt, page-105

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Note in Japan, average GvHD reimbursement per patient is circa A$200,000
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.